Literature DB >> 3495875

Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.

B Hansen, R Manthorpe.   

Abstract

An enzyme-linked immunosorbent assay for detection of serum antibodies against SS-B/La is described, and the frequency of anti-SS-B/La antibodies in 103 blood donors is tested. 67% of patients with primary Sjögren's syndrome (n = 21), verified by at least two abnormal tests for xerostomia as well as keratoconjunctivitis sicca (the Copenhagen criteria), were found to have IgG anti-SS-B antibodies, and 71% had anti-SS-A/Ro precipitating antibodies, when tested by Ouchterlony immunodiffusion. All patients with anti-SS-B/La antibodies had anti-SS-A/Ro antibodies. Anti-SS-A/Ro and -SS-B/La antibodies correlated with the presence of rheumatoid factor, antinuclear antibodies and hypergammaglobulinemia. The clinical manifestations of pseudolymphoma, Raynaud's phenomenon, fatigue and arthralgia, were more frequent in patients with anti-SS-B/La and/or -SS-A/Ro antibodies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3495875

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  3 in total

1.  Clinical differences between ANA/anti-ENA positive or negative primary Sjögren's syndrome.

Authors:  V Fossaluzza; S De Vita
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

2.  Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.

Authors:  F Shokri; R A Mageed; G D Kitas; P Katsikis; H M Moutsopoulos; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome.

Authors:  Michiel M Zandbelt; Judith Vogelzangs; Leo BA Van De Putte; Walther J Van Venrooij; Frank HJ Van Den Hoogen
Journal:  Arthritis Res Ther       Date:  2003-10-31       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.